Interleukin-10_NN
stabilizes_VBZ
inhibitory_JJ
kappaB-alpha_NN
in_IN
human_JJ
monocytes_NNS
._.

Interleukin-10_NN
-LRB-_-LRB-
IL-10_NN
-RRB-_-RRB-
protects_VBZ
animals_NNS
from_IN
lethal_JJ
endotoxemia_NN
._.

This_DT
beneficial_JJ
effect_NN
is_VBZ
mediated_VBN
,_,
in_IN
part_NN
,_,
by_IN
inhibition_NN
of_IN
inflammatory_JJ
cytokine_NN
production_NN
,_,
including_VBG
tumor_NN
necrosis_NN
factor-alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
._.

Evidence_NN
suggests_VBZ
that_IN
IL-10_NN
may_MD
inhibit_VB
activation_NN
of_IN
the_DT
transcription_NN
factor_NN
nuclear_JJ
factor-kappaB_NN
-LRB-_-LRB-
NF-kappaB_NN
-RRB-_-RRB-
through_IN
an_DT
unknown_JJ
mechanism_NN
._.

NF-kappaB_NN
activation_NN
in_IN
response_NN
to_TO
inflammatory_JJ
signals_NNS
is_VBZ
dependent_JJ
upon_IN
degradation_NN
of_IN
its_PRP$
associated_VBN
inhibitory_JJ
peptide_NN
,_,
inhibitory_JJ
kappaB-alpha_NN
-LRB-_-LRB-
IkappaB-alpha_NN
-RRB-_-RRB-
._.

We_PRP
hypothesized_VBD
that_IN
IL-10_NN
prevents_VBZ
human_JJ
monocyte_NN
NF-kappaB_NN
activation_NN
and_CC
resultant_JJ
TNF-alpha_NN
production_NN
by_IN
stabilization_NN
of_IN
IkappaB-alpha_NN
._.

The_DT
purpose_NN
of_IN
this_DT
study_NN
was_VBD
to_TO
determine_VB
the_DT
effect_NN
of_IN
IL-10_NN
on_IN
lipopolysaccharide_NN
-LRB-_-LRB-
LPS_NN
-RRB-_-RRB-
-_:
induced_VBD
human_JJ
monocyte_NN
TNF-alpha_NN
production_NN
,_,
NF-kappaB_NN
activation_NN
,_,
and_CC
IkappaB-alpha_NN
degradation_NN
._.

Monocytes_NNS
were_VBD
isolated_VBN
from_IN
human_JJ
donors_NNS
._.

Cells_NNS
were_VBD
stimulated_VBN
with_IN
endotoxin_NN
-LRB-_-LRB-
LPS_NN
,_,
100_CD
ng\/mL_NN
-RRB-_-RRB-
with_IN
and_CC
without_IN
human_JJ
IL-10_NN
-LRB-_-LRB-
10_CD
ng\/mL_NN
-RRB-_-RRB-
._.

Following_VBG
stimulation_NN
,_,
TNF-alpha_NN
was_VBD
measured_VBN
in_IN
cell_NN
supernatants_NNS
by_IN
ELISA_NN
,_,
NF-kappaB_NN
activity_NN
by_IN
electrophoretic_JJ
mobility_NN
shift_NN
assay_NN
,_,
and_CC
IkappaB-alpha_NN
levels_NNS
by_IN
Western_NN
blot_NN
._.

We_PRP
observed_VBD
that_IN
after_IN
LPS_NN
stimulation_NN
of_IN
human_JJ
monocytes_NNS
,_,
TNF-alpha_NN
increased_VBD
to_TO
798_CD
+_CC
\/_CD
-67_CD
pg\/mL_NN
-LRB-_-LRB-
p_NN
&lt;_JJR
.001_CD
versus_CC
control_NN
-RRB-_-RRB-
._.

IL-10_NN
attenuated_VBD
LPS-stimulated_JJ
TNF-alpha_NN
production_NN
-LRB-_-LRB-
297_CD
+_CC
\/_CD
-54_CD
;_:
p_NN
&lt;_JJR
.001_CD
versus_CC
LPS_NN
alone_RB
-RRB-_-RRB-
._.

After_IN
LPS_NN
stimulation_NN
in_IN
human_JJ
monocytes_NNS
,_,
IkappaB-alpha_NN
protein_NN
levels_NNS
decreased_VBD
,_,
and_CC
NF-kappaB_NN
DNA_NN
binding_NN
increased_VBD
._.

IL-10_NN
pretreatment_NN
prevented_VBD
LPS-induced_JJ
decreases_NNS
in_IN
IkappaB-alpha_NN
protein_NN
levels_NNS
and_CC
attenuated_VBD
NF-kappaB_NN
DNA_NN
binding_NN
._.

IL-10_NN
appears_VBZ
to_TO
prevent_VB
activation_NN
of_IN
NF-kappaB_NN
by_IN
preserving_VBG
IkappaB-alpha_NN
protein_NN
levels_NNS
,_,
leading_VBG
to_TO
a_DT
reduction_NN
in_IN
TNF-alpha_NN
release_NN
._.

